•
AX
AXGN
Axogen, Inc. Common Stock
yahooELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
--
Price Chart
Market Cap
1.52B
Volume
594.06K
52W High
$34.71
52W Low
$9.22
Open
$0.00
Prev Close
$31.87
Day Range
0.00 - 0.00
About Axogen, Inc. Common Stock
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Latest News
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
GlobeNewswire Inc.•8h ago
Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
GlobeNewswire Inc.•Jan 12
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)
GlobeNewswire Inc.•Dec 4
AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm
Benzinga•Oct 1
Global Amniotic Membrane Market Poised for Extraordinary Growth at a CAGR of ~7% by 2032 | DelveInsight
GlobeNewswire Inc.•Jul 30
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
GlobeNewswire Inc.•Feb 11
Bruker Stock Gains From Its Latest Acquisition of Dynamic Biosensors
Benzinga•Oct 7
Here's Why You Should Retain BRKR Stock in Your Portfolio Now
Benzinga•Oct 3